[EN] NEW ARYLALKENYLPROPARGYLAMINE DERIVATIVES EXHIBITING NEUROPROTECTIVE ACTION FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES [FR] NOUVEAUX DÉRIVÉS ARYLALCÉNYLPROPARGYLAMINE FAISANT PREUVE D'ACTION NEUROPROTECTRICE POUR LE TRAITEMENT DES MALADIES NEURODÉGÉNÉRATIVES
A simple and selective method for the synthesis in good yield of 1,3-dibromo-2-phenylprop-1-enes 4 , the starting product to saclofen (GABA-B antagonist), is described.
ABBENANTE, GIOVANNI;PRAGER, ROLF H., AUSTRAL. J. CHEM., 43,(1990) N, C. 213-214